We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$375M
AUM Growth
+$5.98M
Cap. Flow
-$10.7M
Cap. Flow %
-2.85%
Top 10 Hldgs %
17.55%
Holding
221
New
23
Increased
111
Reduced
62
Closed
17

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.47M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.68M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$2.92M
4
CYBR
CyberArk
CYBR
+$2.32M
5
SANM icon
Sanmina
SANM
+$1.37M

Top Sells

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$10.2M
2
INGR icon
Ingredion
INGR
+$8.28M
3
MDU icon
MDU Resources
MDU
+$8.08M
4
DIS icon
Walt Disney
DIS
+$6.24M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$5.34M

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Technology 15.38%
3 Industrials 12.46%
4 Consumer Staples 9.28%
5 Materials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPK icon
201
Opko Health
OPK
$921M
$89K 0.02%
+13,000
New +$82K
TOVX icon
202
Theriva Biologics
TOVX
$10M
$56K 0.01%
+7
New +$40.5K
ARCC icon
203
Ares Capital
ARCC
$13.5B
– –
-10,449
Closed -$171K
AZZ icon
204
AZZ Inc
AZZ
$4.58B
– –
-8,774
Closed -$490K
TDAY
205
USA Today Co
TDAY
$1.24B
– –
-18,444
Closed -$249K
HCKT icon
206
Hackett Group
HCKT
$246M
– –
-26,613
Closed -$413K
OXM icon
207
Oxford Industries
OXM
$576M
– –
-4,298
Closed -$269K
SUPN icon
208
Supernus Pharmaceuticals
SUPN
$2.69B
– –
-124,000
Closed -$5.34M
THRM icon
209
Gentherm
THRM
$1.38B
– –
-12,446
Closed -$483K
MAGN
210
Magnera Corp
MAGN
$485M
– –
-1,181
Closed -$300K
BFX
211
DELISTED
BowFlex Inc.
BFX
– –
-18,770
Closed -$359K
AUTO
212
DELISTED
AutoWeb, Inc. Common Stock
AUTO
– –
-24,199
Closed -$305K
TREC
213
DELISTED
Trecora Resources
TREC
– –
-30,770
Closed -$346K
USCR
214
DELISTED
U S Concrete, Inc.
USCR
– –
-9,066
Closed -$712K
GSB
215
DELISTED
GlobalSCAPE, Inc.
GSB
– –
-108,650
Closed -$575K
DFRG
216
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
– –
-28,560
Closed -$460K
WBMD
217
DELISTED
WebMD Health Corp.
WBMD
– –
-82,725
Closed -$4.85M
DD
218
DELISTED
Du Pont De Nemours E I
DD
– –
-9,567
Closed -$772K
NCIT
219
DELISTED
NCI, Inc.
NCIT
– –
-31,823
Closed -$671K
5 6 7 8
9

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q3 2017 Portfolio in Review

As of Q3 2017, Stanley-Laman Group held 221 positions worth $375M, up 1.6% from $369M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Stanley-Laman Group's Q3 2017 filing shows 23 new, 111 increased, 62 reduced and 17 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M. The largest sale was Palo Alto Networks, an estimated $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Stanley-Laman Group's largest Q3 2017 buy was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M.
  • Stanley-Laman Group added most to Zix Corporation in Q3 2017, an estimated $1.31M increase.
  • Stanley-Laman Group's biggest Q3 2017 reduction was Palo Alto Networks, cutting an estimated $10.2M.
  • Stanley-Laman Group fully exited Supernus Pharmaceuticals in Q3 2017, selling an estimated $5.34M.
  • Stanley-Laman Group's ten largest holdings make up 18% of its $375M portfolio in Q3 2017.
  • Stanley-Laman Group opened 23 new positions and closed 17 in Q3 2017.
  • Stanley-Laman Group's portfolio value rose 1.6% quarter-over-quarter to $375M.

Based on Stanley-Laman Group's 13F filing for Q3 2017, filed 13 Nov 2017.